Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts-Reference-Cited by-同舟云学术

Characterization of humoral and cellular immunity to rubella vaccine in four distinct cohorts

Published:2013-12-28 Issue:1 Volume:58 Page:1-8
ISSN:0257-277X
Container-title:Immunologic Research
language:en
Short-container-title:Immunol Res

Author:

Lambert Nathaniel D.,Haralambieva Iana H.,Ovsyannikova Inna G.,Larrabee Beth R.,Pankratz V. Shane,Poland Gregory A.

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1007/s12026-013-8475-y.pdf

Reference51 articles.

1. Wise J. Small rise in rubella cases triggers warning. BMJ. 2013;346:f2935.

2. Paradowska-Stankiewicz I, Czarkowski MP, Derrough T, Stefanoff P. Ongoing outbreak of rubella among young male adults in Poland: increased risk of congenital rubella infections. Euro Surveill 2013;18(21).

3. Nationwide rubella epidemic in Japan, 2013. Releve epidemiologique hebdomadaire/Section d’hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record/Health Section of the Secretariat of the League of Nations 2013 Jun 14;88(24):251–6.

4. Organization WH. Global measles and rubella strategic plan 2012–2020. Geneva; 2012.

5. Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J. 2001;20(1):63–75.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of adaptive immune cell subsets with measles, mumps, and Rubella−Specific immune response outcomes;Heliyon;2023-12

2. Efficacy of Rubella Vaccination after Co-Inoculation with Rhogam;Viruses;2023-08-22

3. Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy;Frontiers in Oncology;2022-11-09

4. Repurposing Live Attenuated Trivalent MMR Vaccine as Cost-effective Cancer Immunotherapy;2022-03-01

5. Measles, mumps, rubella prevention: how can we do better?;Expert Review of Vaccines;2021-06-07